| Registry | NCT03691480, acronym PNEUM-AMBU |
|---|---|
| Status | Active not recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 148 (Actual) |
| Sponsor | Rennes University Hospital (Other) |
| Conditions | Pneumothorax Spontaneous Primary |
| Interventions | Fuhrman catheter insertion, Three-way stopcock open, Manual aspiration (Procedure) |
| Dates | start 2021-09-17, primary completion 2026-09-24, completion 2027-09-16 (estimated), first posted 2018-10-01, last updated 2026-10-22 |
| Locations | 5 sites in France |
Related Papers Related Patents Related Grants Related Experts
All trials for Pneumothorax Spontaneous Primary All trials of Fuhrman catheter insertion All trials of Three-way stopcock open
The management of large spontaneous pneumothorax is not consensual. Current practice involves placement of a Fuhrman catheter connected to a one-way valve, with outpatient monitoring in pneumology consultation. Manual aspiration is a widely used alternative, but the two approaches have never been directly compared in a prospective study.
The main objective of this randomized trial is to compare the efficacy of these two ambulatory strategies in adults with an episode of large unilateral primary spontaneous pneumothorax. We hypothesize that management with a Fuhrman catheter and one-way valve is superior to manual aspiration.
This is a multicenter, randomized, open-label, parallel-group superiority trial. Eligible patients are adults (between 18 years old and 50 years old) presenting to the emergency department of a participating center with a large unilateral primary spontaneous pneumothorax. After information and written consent, patients are randomized on Day 0 to one of two arms :
* ambulatory management with pigtail catheter connected to one-way valve as previously published (Voisin F et al. Ann Emerg Med 2014; Sale A et al. Respir Med 2020) or
* manual aspiration as described in international guidelines.
Large pneumothorax is defined according to BTS, ACCP and/or French guidelines as a separation of ≥ 2 cm at the hilum, and/or ≥ 3 cm at the apex, and/or ≥ 2 cm over the whole height on an axillary view. Complete or near-complete re-expansion means a residual pneumothorax below these thresholds; otherwise the pneumothorax is considered persistent.
In both arms, failure is defined as hospitalization. In the manual aspiration arm, it also includes switching to the one-way valve arm (circuit reopened, valve connected), which is immediate (Day 0, Hour 0) if an aspirated volume of ≥ 2 L (40 syringes) is reached. The patient then receives usual care.
3\) Other data collected. All patients are seen on Day 2, Day 6 and, if needed, Day 4, with a standard pulmonology history and clinical examination. Pain and analgesic consumption are recorded daily from Day 1 to Day 6, together with adverse events. Pain is also assessed at catheter removal.
4\) Long-term follow-up. Patients are contacted at Months 3, 6, 9 and 12 to document pneumothorax recurrence and pleurodesis.
5\) Previous inclusion / Repeat episodes Patients already included in this study for a previous large PSP episode are not eligible.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| One-way valve | Active comparator | Procedure: Fuhrman catheter insertion; Procedure: Three-way stopcock open | Ambulatory management with the Fuhrman catheter connected to a one-way valve, with chest X-ray follow-up on Day 0, Day 2, Day 4 if needed, and Day 6. |
| Manual aspiration | Experimental | Procedure: Fuhrman catheter insertion; Procedure: Manual aspiration | Manual aspiration with 50 mL syringes through the Fuhrman catheter on Day 0 (optional second aspiration), followed by closure of the three-way stopcock, with chest X-rays at Hour 4, Hour 8 (if applicable), Day 2 and Day 6. An aspirated volume ≥ 2 L (40 syringes), a persistent large pneumothorax after the last aspiration or on Day 2 leads to reopening of the circuit and connection of the one-way valve (failure). |
Sex: All, ages: 18 Years to 50 Years
* Inclusion Criteria : * Episode of large unilateral primary spontaneous pneumothorax according to British Thoracic Society (BTS), American College of Chest Physicians (ACCP) and/or French guidelines, defined as : a separation of ≥ 2 cm at the hilum, and/or ≥ 3 cm at the apex, and/or ≥ 2 cm over the whole height on an axillary view * Free and informed consent of the patient * Exclusion Criteria : * Impossibility of ambulatory management, at the clinician's discretion * Inability to follow or understand the study procedures * Secondary pneumothorax, i.e. associated with an underlying chronic respiratory disease such as chronic obstructive pulmonary disease (COPD), emphysema, asthma, cystic fibrosis or pulmonary fibrosis * Non-spontaneous pneumothorax: traumatic or iatrogenic * Protected persons: adults under legal protection (judicial protection, curatorship or guardianship), persons deprived of liberty, pregnant women (self-reported), breastfeeding women, and minors
| Facility | City | Country | Status |
|---|---|---|---|
| Centre 02 - Groupe Hospitalier de Bretagne Sud, Hôpital du Scorff | Lorient | France | |
| Centre 01 - CHU de RENNES, Hôpital Pontchaillou | Rennes | France | |
| Centre 04 - GHSO, CH Selestat | Sélestat | France | |
| Centre 03 - GHRE, CH Saint-Malo | St-Malo | France | |
| Centre 05 - CHU Toulouse, Hôpital Larrey | Toulouse | France |